Stock market week-in-review for 5 large GI companies — July 31-Aug. 4

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 31 to Aug. 4.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $253.07 on July 31
Peaked: $255.22 on July 31
Closed: $242.55 on Aug. 4
Percent change between July 31 and Aug. 4: -4.15 percent

2. Exact Sciences Corp.

Opened: $39.47 on July 31
Peaked: $39.59 on July 31
Closed: $38.69 on Aug. 4
Percent change between July 31 and Aug. 4: -1.97 percent

3. Johnson & Johnson

Opened: $131.84 on July 31
Peaked: $133.91 on Aug. 4
Closed: $133.11 on Aug. 4
Percent change between July 31 and Aug. 4: 0.96 percent

4. Synergy Pharmaceuticals

Opened: $4.06 on July 31
Peaked at open
Closed: $3.72 on Aug. 4
Percent change between July 31 and Aug. 4: -8.37 percent

5. Valeant Pharmaceuticals

Opened: $16.87 on July 31
Peaked at open
Closed: $15.12 on Aug. 4
Percent change between July 31 and Aug. 4: -10.37 percent

More articles on gastroenterology:
Ironwood Pharmaceuticals reports Q2 revenues of $65.1M — 4 insights
GI center to know: Gastro Group & EndoCenter
GI leader to know: Dr. Anthony Albright of Gastro Group & EndoCenter

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.